Expert Tip from Cervey

img
img

TIP: Prioritize referral consistency over volume.


When it comes to 340B referral capture, it’s tempting to focus

Read More »
Industry Insights Logo

Stretching Scarce Federal Resources: How Conway Medical Center Is Redefining 340B’s Impact

SPONSORED CONTENT

The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient.

Read More »

Expert Tip from Ravin Consultants

img
img

TIP: Ensure behavioral health medications are fully integrated into your 340B strategy to maximize patient access and program savings.


Read More »
Industry Insights Logo

Don’t Overlook the Importance of an HIN on Your Wholesale Accounts

SPONSORED CONTENT

It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is

Read More »
Industry Insights Logo

Effective Contract Pharmacy Strategies in an Ever-Changing Landscape

SPONSORED CONTENT

W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, “Uncontrolled variation is the enemy of quality.” In the realm of 340B, including 340B contract pharmacies, that change is both continual and constant.

Read More »
Industry Insights Logo

Navigating the Complexities of Specialty Medication Claims Processing

SPONSORED CONTENT

The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims processing. While this may be true in certain circumstances, organizations providing or considering offering specialty medications can still successfully navigate these complexities with

Read More »
Industry Insights Logo

Setting the Record Straight

SPONSORED CONTENT

The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of

Read More »
Industry Insights Logo

How to Maximize Partner Support for Referral Capture During a HRSA Audit

SPONSORED CONTENT

A HRSA audit is not a question of if but when. Therefore, it is crucial for covered entities (CEs) to always remain audit-ready. The 340B program has become increasingly complex over the years, prompting service provider partners (partners) in the

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live